Cargando…
Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837228/ https://www.ncbi.nlm.nih.gov/pubmed/34756359 http://dx.doi.org/10.1016/j.jmii.2020.09.007 |
_version_ | 1783642918887620608 |
---|---|
author | Chuang, Tzu-Yi Tsai, Ming-Han Wu, Lit-Min Ho, Sung-Jung Yeh, Pu-Sheng Liu, Yi-Lien Fred Yang, Hung-Jen |
author_facet | Chuang, Tzu-Yi Tsai, Ming-Han Wu, Lit-Min Ho, Sung-Jung Yeh, Pu-Sheng Liu, Yi-Lien Fred Yang, Hung-Jen |
author_sort | Chuang, Tzu-Yi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7837228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78372282021-01-26 Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19 Chuang, Tzu-Yi Tsai, Ming-Han Wu, Lit-Min Ho, Sung-Jung Yeh, Pu-Sheng Liu, Yi-Lien Fred Yang, Hung-Jen J Microbiol Immunol Infect Correspondence Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2021-02 2020-10-03 /pmc/articles/PMC7837228/ /pubmed/34756359 http://dx.doi.org/10.1016/j.jmii.2020.09.007 Text en © 2020 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Chuang, Tzu-Yi Tsai, Ming-Han Wu, Lit-Min Ho, Sung-Jung Yeh, Pu-Sheng Liu, Yi-Lien Fred Yang, Hung-Jen Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19 |
title | Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19 |
title_full | Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19 |
title_fullStr | Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19 |
title_full_unstemmed | Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19 |
title_short | Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19 |
title_sort | successful treatment of tocilizumab and ivermectin for a patient with ards due to covid-19 |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837228/ https://www.ncbi.nlm.nih.gov/pubmed/34756359 http://dx.doi.org/10.1016/j.jmii.2020.09.007 |
work_keys_str_mv | AT chuangtzuyi successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19 AT tsaiminghan successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19 AT wulitmin successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19 AT hosungjung successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19 AT yehpusheng successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19 AT liuyilien successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19 AT fredyanghungjen successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19 |